市場調查報告書
商品編碼
1411274
血液培養測試市場規模-按產品(儀器、消耗品)、方法(傳統、自動化)、技術(培養、分子、蛋白質組)、應用(細菌、真菌感染)、最終用途(診斷中心、醫院)和預測2024-2032Blood Culture Tests Market Size-By Product (Instrument, Consumable), Method (Conventional, Automated), Technology (Culture, Molecular, Proteomic), Application (Bacterial, Fungal Infections), End-use (Diagnostic Center, Hospital), & Forecast 2024-2032 |
預計從 2024 年到 2032 年,血液培養測試市場規模將以 7.9% 的CAGR擴大。全球範圍內血液感染和膿毒症發病率的不斷增加凸顯了對準確、快速診斷工具的迫切需求。血液培養系統技術的不斷進步促進了病原體的更快檢測和識別,這導致了對此類測試的更高需求。例如,2023 年6 月,印度診斷公司Mylab Discovery Solutions 推出了PathoCatch 鐮狀細胞快速檢測,這是一種針對鐮狀細胞貧血的條狀照護端檢測,透過直接提供快速、準確的結果,徹底改變了SCA 診斷和管理在患者所在位置。
自動化系統的日益普及正在推動人們不斷努力提高血液培養測試的敏感度和特異性。對病人安全的日益重視,提高了醫療保健專業人員對早期、準確診斷血流感染重要性的認知。將分子診斷整合到血液培養檢測方法中也將補充產業的成長。
血液培養測試市場分為產品、方法、技術、應用、最終用途和區域。
根據產品類型,由於對先進血液培養系統的需求不斷增加,2024年至2032年儀器領域的產業價值預計將以8.1%的CAGR成長。持續的技術進步,例如分子診斷的自動化和整合,也將有助於提高這些儀器的功效,推動產品的採用。
由於人們對高效、高通量診斷解決方案的日益青睞,自動化方法領域的血液培養測試市場佔有率預計到 2032 年CAGR將達到 8%。自動化血液培養系統可提供快速、精確的病原體檢測,進而縮短週轉時間。自動化方法也提高了血液培養測試的整體效率,推動了該細分市場的成長。
從區域來看,亞太地區血液培養測試市場預計在 2024 年至 2032 年間將以 8.5% 的CAGR擴張。這種成長可歸因於傳染病發病率的上升、人們對早期準確診斷重要性的認知不斷提高以及醫療保健水準的提高基礎設施改善。對有效感染控制措施的日益重視和診斷程序的持續技術進步也將推動區域市場的擴張。
Blood culture tests market size is projected to expand at 7.9% CAGR from 2024 to 2032. The increasing incidences of bloodstream infections and sepsis across the globe is emphasizing the critical need for accurate and rapid diagnostic tools. The rising technological advancements in blood culture systems for promoting quicker detection and identification of pathogens is contributing to the higher demand for such tests. For instance, in June 2023, Mylab Discovery Solutions, an Indian diagnostic company, introduced PathoCatch Sickle Cell Rapid Test, a strip-based point-of-care test for Sickle Cell Anemia to revolutionize SCA diagnosis and management by providing fast and accurate results directly at the patient's location.
The growing adoption of automated systems is driving continuous efforts to enhance the sensitivity and specificity of blood culture tests. The growing emphasis on patient safety is increasing the awareness among healthcare professionals about the importance of early and precise diagnosis of bloodstream infections. The integration of molecular diagnostics into blood culture testing methodologies will also complement the industry growth.
The blood culture tests market is categorized into product, method, technology, application, end-use, and region.
Based on product type, the industry value from the instruments segment is projected to rise at 8.1% CAGR from 2024 to 2032, owing to the increasing demand for advanced blood culture systems. The ongoing technological advancements, such as automation and integration of molecular diagnostics, will also contribute to the efficacy of these instruments, driving the product adoption.
Blood culture tests market share from the automated method segment is estimated to witness 8% CAGR through 2032, due to the growing preference for efficient and high-throughput diagnostic solutions. Automated blood culture systems offer rapid and precise pathogen detection in reducing turnaround times. The automation method also enhances the overall efficiency of blood culture testing, pushing the segment growth ahead.
Regionally, the Asia Pacific blood culture tests market is projected to expand at 8.5% CAGR between 2024 and 2032. The growth can be attributed to the rising incidence of infectious diseases, increased awareness about the importance of early and accurate diagnostics, and the higher healthcare infrastructure improvements. The growing emphasis on effective infection control measures and continuous technological advancements in diagnostic procedures will also fuel the regional market expansion.